Moore Capital Management’s Abbott ABT Stock Holding History

Moore Capital Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-300,000	Closed	-$14.7M	–	278
2015 Q2	$14.7M	Buy	+300,000	New	+$14.4M	0.32%	67
2014 Q3	–	Sell	-200,000	Closed	-$8.18M	–	391
2014 Q2	$8.18M	Buy	+200,000	New	+$7.85M	0.2%	124

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Moore Capital Management's ABT Position: Q3 2014 in Review

Moore Capital Management sold out of Abbott (ABT) in Q3 2014, closing a stake of 10,998 shares — an estimated $450K sold.

Moore Capital Management first reported a position in ABT in Q1 2014 and held it in 2 quarters. The position peaked at $450K in Q2 2014. 1,400 funds tracked by Wall St. Rank hold ABT as of Q3 2014.

Moore Capital Management reported no remaining Abbott position as of Q3 2014 after selling out during the quarter.
Moore Capital Management sold 10,998 Abbott shares in Q3 2014, an estimated $450K.
Moore Capital Management first reported a position in Abbott in Q1 2014 and held it in 2 quarters.
Moore Capital Management's Abbott position peaked at $450K in Q2 2014.
1,400 funds tracked by Wall St. Rank held Abbott as of Q3 2014.

Based on Moore Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.